Mass Balance Study of [14C]LC350189 in Healthy Volunteers

Summary

This is a Phase 1, open-label, single-dose, mass balance study designed to evaluate the absorption, metabolism, and excretion of \[14C\] radiolabeled LC350189 after oral administration.

Timeline

Start

2020-02-26

Primary completion

2020-03-07

Completion

2020-03-07

Drugs

Indications